Castlight Health, inc. (NYSE:CSLT) has been assigned a consensus rating of “Hold” from the ten analysts that are presently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $4.45.

A number of equities research analysts recently weighed in on CSLT shares. Zacks Investment Research upgraded Castlight Health, inc. from a “sell” rating to a “hold” rating in a research note on Tuesday, June 27th. BidaskClub upgraded Castlight Health, inc. from a “hold” rating to a “buy” rating in a research note on Wednesday, July 12th. Chardan Capital started coverage on Castlight Health, inc. in a research note on Tuesday, June 6th. They set a “buy” rating and a $4.50 price objective for the company. Cowen and Company restated a “market perform” rating and set a $4.50 price objective (up from $4.00) on shares of Castlight Health, inc. in a research note on Thursday, August 3rd. Finally, ValuEngine upgraded Castlight Health, inc. from a “sell” rating to a “hold” rating in a research note on Tuesday, August 1st.

Castlight Health, inc. (CSLT) opened at 4.25 on Friday. The stock’s 50 day moving average price is $3.98 and its 200 day moving average price is $3.90. Castlight Health, inc. has a one year low of $3.05 and a one year high of $5.50. The company’s market capitalization is $559.67 million.

Castlight Health, inc. (NYSE:CSLT) last issued its quarterly earnings data on Wednesday, August 2nd. The software maker reported ($0.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.02. The firm had revenue of $32.10 million during the quarter, compared to analysts’ expectations of $31.14 million. Castlight Health, inc. had a negative return on equity of 36.30% and a negative net margin of 42.54%. The firm’s quarterly revenue was up 36.0% on a year-over-year basis. During the same period in the prior year, the business posted ($0.11) EPS. Equities analysts anticipate that Castlight Health, inc. will post ($0.25) EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This report was first reported by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another site, it was stolen and reposted in violation of international copyright & trademark law. The original version of this report can be read at https://www.americanbankingnews.com/2017/09/23/castlight-health-inc-cslt-receives-average-rating-of-hold-from-analysts.html.

In related news, insider Giovanni M. Colella sold 23,000 shares of the company’s stock in a transaction dated Wednesday, August 9th. The stock was sold at an average price of $4.06, for a total transaction of $93,380.00. Following the transaction, the insider now directly owns 78,906 shares of the company’s stock, valued at approximately $320,358.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO John C. Doyle sold 35,184 shares of the company’s stock in a transaction dated Thursday, August 17th. The shares were sold at an average price of $3.65, for a total value of $128,421.60. Following the transaction, the chief executive officer now directly owns 75,639 shares in the company, valued at $276,082.35. The disclosure for this sale can be found here. Insiders have sold a total of 208,287 shares of company stock worth $795,240 over the last ninety days. 37.43% of the stock is currently owned by corporate insiders.

A number of large investors have recently made changes to their positions in the stock. FMR LLC increased its position in Castlight Health, inc. by 49.2% during the 2nd quarter. FMR LLC now owns 11,433,928 shares of the software maker’s stock valued at $47,451,000 after buying an additional 3,768,009 shares in the last quarter. Vanguard Group Inc. increased its position in Castlight Health, inc. by 36.0% during the 2nd quarter. Vanguard Group Inc. now owns 3,636,948 shares of the software maker’s stock valued at $15,094,000 after buying an additional 963,188 shares in the last quarter. Prudential PLC increased its position in Castlight Health, inc. by 23.5% during the 2nd quarter. Prudential PLC now owns 2,002,706 shares of the software maker’s stock valued at $8,311,000 after buying an additional 380,920 shares in the last quarter. Gagnon Securities LLC increased its position in Castlight Health, inc. by 2.5% during the 1st quarter. Gagnon Securities LLC now owns 1,446,792 shares of the software maker’s stock valued at $5,281,000 after buying an additional 35,374 shares in the last quarter. Finally, Maverick Capital Ltd. increased its position in Castlight Health, inc. by 2.8% during the 2nd quarter. Maverick Capital Ltd. now owns 1,221,809 shares of the software maker’s stock valued at $5,071,000 after buying an additional 33,735 shares in the last quarter. 41.29% of the stock is currently owned by institutional investors.

Castlight Health, inc. Company Profile

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Analyst Recommendations for Castlight Health, inc. (NYSE:CSLT)

Receive News & Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related companies with MarketBeat.com's FREE daily email newsletter.